Analyst Ratings for BioMarin Pharmaceutical Inc. (BMRN)
BMRN Rating Summary
BMRN Price Target Summary
- Highest: $122.00 (Morgan Stanley)
- Lowest: $60.00 (H.C. Wainwright)
- Average: $90.15
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$90.15 (+61.1%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
Percentile Rank: 75%
Avg. $ Target:
$90.15 (+61.1%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
Percentile Rank: 75%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/12/2026 | Raymond James | Chris Raymond | Upgrade | Strong Buy (Outperform) |
109.00 (N/A) |
54.80 (55.95) |
2.1% | Details |
| 8/18/2026 | BMO Capital » Updated 9/16/2026 |
David Lebowitz | New Coverage | Outperform (N/A) |
97.00 (98.00) |
66.64 (55.95) |
-16.04% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
